Global Flu Vaccine Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

Description

According to our (Global Info Research) latest study, the global Flu Vaccine market size was valued at USD 8056.5 million in 2022 and is forecast to a readjusted size of USD 11570 million by 2029 with a CAGR of 5.3% during review period.

Influenza vaccines, also known as flu shots, are vaccines that protect against influenza. A new version of the vaccine is developed twice a year as the influenza virus rapidly changes. Most provide modest to high protection against influenza; however, each year this varies. Evidence in adults over 65 years old is poor. They decrease the number of missed days of work by a half day on average. Vaccinating children may protect those around them.

Global key players of Vaccine for Influenza include Sanofi, CSL and GSK, etc. The top five players hold a share about 75%. North America is the largest market, has a share about 50%.

The Global Info Research report includes an overview of the development of the Flu Vaccine industry chain, the market status of 6 Months to 3 Years (Trivalent Influenza Vaccine, Quadrivalent Influenza Vaccine), > 3 Years (Trivalent Influenza Vaccine, Quadrivalent Influenza Vaccine), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Flu Vaccine.

Regionally, the report analyzes the Flu Vaccine markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Flu Vaccine market, with robust domestic demand, supportive policies, and a strong manufacturing base.

Key Features:
The report presents comprehensive understanding of the Flu Vaccine market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Flu Vaccine industry.

The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the sales quantity (M Doses), revenue generated, and market share of different by Type (e.g., Trivalent Influenza Vaccine, Quadrivalent Influenza Vaccine).

Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Flu Vaccine market.

Regional Analysis: The report involves examining the Flu Vaccine market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.

Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Flu Vaccine market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.

The report also involves a more granular approach to Flu Vaccine:
Company Analysis: Report covers individual Flu Vaccine manufacturers, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.

Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Flu Vaccine This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (6 Months to 3 Years, > 3 Years).

Technology Analysis: Report covers specific technologies relevant to Flu Vaccine. It assesses the current state, advancements, and potential future developments in Flu Vaccine areas.

Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Flu Vaccine market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.

Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.

Market Segmentation
Flu Vaccine market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.

Market segment by Type
    Trivalent Influenza Vaccine
    Quadrivalent Influenza Vaccine

Market segment by Application
    6 Months to 3 Years
    > 3 Years

Major players covered
    Sanofi
    CSL
    GSK
    Viatris
    AstraZeneca
    Hualan Bio
    Changchun Institute of Biological
    Sinovac
    BCHT
    Jiangsu GDK
    KM Biologics

Market segment by region, regional analysis covers
    North America (United States, Canada and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Flu Vaccine product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Flu Vaccine, with price, sales, revenue and global market share of Flu Vaccine from 2018 to 2023.
Chapter 3, the Flu Vaccine competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Flu Vaccine breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Flu Vaccine market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Flu Vaccine.
Chapter 14 and 15, to describe Flu Vaccine sales channel, distributors, customers, research findings and conclusion.

Table of Contents

1 Market Overview
    1.1 Product Overview and Scope of Flu Vaccine
    1.2 Market Estimation Caveats and Base Year
    1.3 Market Analysis by Type
        1.3.1 Overview: Global Flu Vaccine Consumption Value by Type: 2018 Versus 2022 Versus 2029
        1.3.2 Trivalent Influenza Vaccine
        1.3.3 Quadrivalent Influenza Vaccine
    1.4 Market Analysis by Application
        1.4.1 Overview: Global Flu Vaccine Consumption Value by Application: 2018 Versus 2022 Versus 2029
        1.4.2 6 Months to 3 Years
        1.4.3 > 3 Years
    1.5 Global Flu Vaccine Market Size & Forecast
        1.5.1 Global Flu Vaccine Consumption Value (2018 & 2022 & 2029)
        1.5.2 Global Flu Vaccine Sales Quantity (2018-2029)
        1.5.3 Global Flu Vaccine Average Price (2018-2029)

2 Manufacturers Profiles
    2.1 Sanofi
        2.1.1 Sanofi Details
        2.1.2 Sanofi Major Business
        2.1.3 Sanofi Flu Vaccine Product and Services
        2.1.4 Sanofi Flu Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.1.5 Sanofi Recent Developments/Updates
    2.2 CSL
        2.2.1 CSL Details
        2.2.2 CSL Major Business
        2.2.3 CSL Flu Vaccine Product and Services
        2.2.4 CSL Flu Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.2.5 CSL Recent Developments/Updates
    2.3 GSK
        2.3.1 GSK Details
        2.3.2 GSK Major Business
        2.3.3 GSK Flu Vaccine Product and Services
        2.3.4 GSK Flu Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.3.5 GSK Recent Developments/Updates
    2.4 Viatris
        2.4.1 Viatris Details
        2.4.2 Viatris Major Business
        2.4.3 Viatris Flu Vaccine Product and Services
        2.4.4 Viatris Flu Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.4.5 Viatris Recent Developments/Updates
    2.5 AstraZeneca
        2.5.1 AstraZeneca Details
        2.5.2 AstraZeneca Major Business
        2.5.3 AstraZeneca Flu Vaccine Product and Services
        2.5.4 AstraZeneca Flu Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.5.5 AstraZeneca Recent Developments/Updates
    2.6 Hualan Bio
        2.6.1 Hualan Bio Details
        2.6.2 Hualan Bio Major Business
        2.6.3 Hualan Bio Flu Vaccine Product and Services
        2.6.4 Hualan Bio Flu Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.6.5 Hualan Bio Recent Developments/Updates
    2.7 Changchun Institute of Biological
        2.7.1 Changchun Institute of Biological Details
        2.7.2 Changchun Institute of Biological Major Business
        2.7.3 Changchun Institute of Biological Flu Vaccine Product and Services
        2.7.4 Changchun Institute of Biological Flu Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.7.5 Changchun Institute of Biological Recent Developments/Updates
    2.8 Sinovac
        2.8.1 Sinovac Details
        2.8.2 Sinovac Major Business
        2.8.3 Sinovac Flu Vaccine Product and Services
        2.8.4 Sinovac Flu Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.8.5 Sinovac Recent Developments/Updates
    2.9 BCHT
        2.9.1 BCHT Details
        2.9.2 BCHT Major Business
        2.9.3 BCHT Flu Vaccine Product and Services
        2.9.4 BCHT Flu Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.9.5 BCHT Recent Developments/Updates
    2.10 Jiangsu GDK
        2.10.1 Jiangsu GDK Details
        2.10.2 Jiangsu GDK Major Business
        2.10.3 Jiangsu GDK Flu Vaccine Product and Services
        2.10.4 Jiangsu GDK Flu Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.10.5 Jiangsu GDK Recent Developments/Updates
    2.11 KM Biologics
        2.11.1 KM Biologics Details
        2.11.2 KM Biologics Major Business
        2.11.3 KM Biologics Flu Vaccine Product and Services
        2.11.4 KM Biologics Flu Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.11.5 KM Biologics Recent Developments/Updates

3 Competitive Environment: Flu Vaccine by Manufacturer
    3.1 Global Flu Vaccine Sales Quantity by Manufacturer (2018-2023)
    3.2 Global Flu Vaccine Revenue by Manufacturer (2018-2023)
    3.3 Global Flu Vaccine Average Price by Manufacturer (2018-2023)
    3.4 Market Share Analysis (2022)
        3.4.1 Producer Shipments of Flu Vaccine by Manufacturer Revenue ($MM) and Market Share (%): 2022
        3.4.2 Top 3 Flu Vaccine Manufacturer Market Share in 2022
        3.4.2 Top 6 Flu Vaccine Manufacturer Market Share in 2022
    3.5 Flu Vaccine Market: Overall Company Footprint Analysis
        3.5.1 Flu Vaccine Market: Region Footprint
        3.5.2 Flu Vaccine Market: Company Product Type Footprint
        3.5.3 Flu Vaccine Market: Company Product Application Footprint
    3.6 New Market Entrants and Barriers to Market Entry
    3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region
    4.1 Global Flu Vaccine Market Size by Region
        4.1.1 Global Flu Vaccine Sales Quantity by Region (2018-2029)
        4.1.2 Global Flu Vaccine Consumption Value by Region (2018-2029)
        4.1.3 Global Flu Vaccine Average Price by Region (2018-2029)
    4.2 North America Flu Vaccine Consumption Value (2018-2029)
    4.3 Europe Flu Vaccine Consumption Value (2018-2029)
    4.4 Asia-Pacific Flu Vaccine Consumption Value (2018-2029)
    4.5 South America Flu Vaccine Consumption Value (2018-2029)
    4.6 Middle East and Africa Flu Vaccine Consumption Value (2018-2029)

5 Market Segment by Type
    5.1 Global Flu Vaccine Sales Quantity by Type (2018-2029)
    5.2 Global Flu Vaccine Consumption Value by Type (2018-2029)
    5.3 Global Flu Vaccine Average Price by Type (2018-2029)

6 Market Segment by Application
    6.1 Global Flu Vaccine Sales Quantity by Application (2018-2029)
    6.2 Global Flu Vaccine Consumption Value by Application (2018-2029)
    6.3 Global Flu Vaccine Average Price by Application (2018-2029)

7 North America
    7.1 North America Flu Vaccine Sales Quantity by Type (2018-2029)
    7.2 North America Flu Vaccine Sales Quantity by Application (2018-2029)
    7.3 North America Flu Vaccine Market Size by Country
        7.3.1 North America Flu Vaccine Sales Quantity by Country (2018-2029)
        7.3.2 North America Flu Vaccine Consumption Value by Country (2018-2029)
        7.3.3 United States Market Size and Forecast (2018-2029)
        7.3.4 Canada Market Size and Forecast (2018-2029)
        7.3.5 Mexico Market Size and Forecast (2018-2029)

8 Europe
    8.1 Europe Flu Vaccine Sales Quantity by Type (2018-2029)
    8.2 Europe Flu Vaccine Sales Quantity by Application (2018-2029)
    8.3 Europe Flu Vaccine Market Size by Country
        8.3.1 Europe Flu Vaccine Sales Quantity by Country (2018-2029)
        8.3.2 Europe Flu Vaccine Consumption Value by Country (2018-2029)
        8.3.3 Germany Market Size and Forecast (2018-2029)
        8.3.4 France Market Size and Forecast (2018-2029)
        8.3.5 United Kingdom Market Size and Forecast (2018-2029)
        8.3.6 Russia Market Size and Forecast (2018-2029)
        8.3.7 Italy Market Size and Forecast (2018-2029)

9 Asia-Pacific
    9.1 Asia-Pacific Flu Vaccine Sales Quantity by Type (2018-2029)
    9.2 Asia-Pacific Flu Vaccine Sales Quantity by Application (2018-2029)
    9.3 Asia-Pacific Flu Vaccine Market Size by Region
        9.3.1 Asia-Pacific Flu Vaccine Sales Quantity by Region (2018-2029)
        9.3.2 Asia-Pacific Flu Vaccine Consumption Value by Region (2018-2029)
        9.3.3 China Market Size and Forecast (2018-2029)
        9.3.4 Japan Market Size and Forecast (2018-2029)
        9.3.5 Korea Market Size and Forecast (2018-2029)
        9.3.6 India Market Size and Forecast (2018-2029)
        9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
        9.3.8 Australia Market Size and Forecast (2018-2029)

10 South America
    10.1 South America Flu Vaccine Sales Quantity by Type (2018-2029)
    10.2 South America Flu Vaccine Sales Quantity by Application (2018-2029)
    10.3 South America Flu Vaccine Market Size by Country
        10.3.1 South America Flu Vaccine Sales Quantity by Country (2018-2029)
        10.3.2 South America Flu Vaccine Consumption Value by Country (2018-2029)
        10.3.3 Brazil Market Size and Forecast (2018-2029)
        10.3.4 Argentina Market Size and Forecast (2018-2029)

11 Middle East & Africa
    11.1 Middle East & Africa Flu Vaccine Sales Quantity by Type (2018-2029)
    11.2 Middle East & Africa Flu Vaccine Sales Quantity by Application (2018-2029)
    11.3 Middle East & Africa Flu Vaccine Market Size by Country
        11.3.1 Middle East & Africa Flu Vaccine Sales Quantity by Country (2018-2029)
        11.3.2 Middle East & Africa Flu Vaccine Consumption Value by Country (2018-2029)
        11.3.3 Turkey Market Size and Forecast (2018-2029)
        11.3.4 Egypt Market Size and Forecast (2018-2029)
        11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
        11.3.6 South Africa Market Size and Forecast (2018-2029)

12 Market Dynamics
    12.1 Flu Vaccine Market Drivers
    12.2 Flu Vaccine Market Restraints
    12.3 Flu Vaccine Trends Analysis
    12.4 Porters Five Forces Analysis
        12.4.1 Threat of New Entrants
        12.4.2 Bargaining Power of Suppliers
        12.4.3 Bargaining Power of Buyers
        12.4.4 Threat of Substitutes
        12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain
    13.1 Raw Material of Flu Vaccine and Key Manufacturers
    13.2 Manufacturing Costs Percentage of Flu Vaccine
    13.3 Flu Vaccine Production Process
    13.4 Flu Vaccine Industrial Chain

14 Shipments by Distribution Channel
    14.1 Sales Channel
        14.1.1 Direct to End-User
        14.1.2 Distributors
    14.2 Flu Vaccine Typical Distributors
    14.3 Flu Vaccine Typical Customers

15 Research Findings and Conclusion

16 Appendix
    16.1 Methodology
    16.2 Research Process and Data Source
    16.3 Disclaimer

Table of Figures

List of Tables
    Table 1. Global Flu Vaccine Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
    Table 2. Global Flu Vaccine Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
    Table 3. Sanofi Basic Information, Manufacturing Base and Competitors
    Table 4. Sanofi Major Business
    Table 5. Sanofi Flu Vaccine Product and Services
    Table 6. Sanofi Flu Vaccine Sales Quantity (M Doses), Average Price (USD/Doses), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 7. Sanofi Recent Developments/Updates
    Table 8. CSL Basic Information, Manufacturing Base and Competitors
    Table 9. CSL Major Business
    Table 10. CSL Flu Vaccine Product and Services
    Table 11. CSL Flu Vaccine Sales Quantity (M Doses), Average Price (USD/Doses), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 12. CSL Recent Developments/Updates
    Table 13. GSK Basic Information, Manufacturing Base and Competitors
    Table 14. GSK Major Business
    Table 15. GSK Flu Vaccine Product and Services
    Table 16. GSK Flu Vaccine Sales Quantity (M Doses), Average Price (USD/Doses), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 17. GSK Recent Developments/Updates
    Table 18. Viatris Basic Information, Manufacturing Base and Competitors
    Table 19. Viatris Major Business
    Table 20. Viatris Flu Vaccine Product and Services
    Table 21. Viatris Flu Vaccine Sales Quantity (M Doses), Average Price (USD/Doses), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 22. Viatris Recent Developments/Updates
    Table 23. AstraZeneca Basic Information, Manufacturing Base and Competitors
    Table 24. AstraZeneca Major Business
    Table 25. AstraZeneca Flu Vaccine Product and Services
    Table 26. AstraZeneca Flu Vaccine Sales Quantity (M Doses), Average Price (USD/Doses), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 27. AstraZeneca Recent Developments/Updates
    Table 28. Hualan Bio Basic Information, Manufacturing Base and Competitors
    Table 29. Hualan Bio Major Business
    Table 30. Hualan Bio Flu Vaccine Product and Services
    Table 31. Hualan Bio Flu Vaccine Sales Quantity (M Doses), Average Price (USD/Doses), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 32. Hualan Bio Recent Developments/Updates
    Table 33. Changchun Institute of Biological Basic Information, Manufacturing Base and Competitors
    Table 34. Changchun Institute of Biological Major Business
    Table 35. Changchun Institute of Biological Flu Vaccine Product and Services
    Table 36. Changchun Institute of Biological Flu Vaccine Sales Quantity (M Doses), Average Price (USD/Doses), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 37. Changchun Institute of Biological Recent Developments/Updates
    Table 38. Sinovac Basic Information, Manufacturing Base and Competitors
    Table 39. Sinovac Major Business
    Table 40. Sinovac Flu Vaccine Product and Services
    Table 41. Sinovac Flu Vaccine Sales Quantity (M Doses), Average Price (USD/Doses), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 42. Sinovac Recent Developments/Updates
    Table 43. BCHT Basic Information, Manufacturing Base and Competitors
    Table 44. BCHT Major Business
    Table 45. BCHT Flu Vaccine Product and Services
    Table 46. BCHT Flu Vaccine Sales Quantity (M Doses), Average Price (USD/Doses), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 47. BCHT Recent Developments/Updates
    Table 48. Jiangsu GDK Basic Information, Manufacturing Base and Competitors
    Table 49. Jiangsu GDK Major Business
    Table 50. Jiangsu GDK Flu Vaccine Product and Services
    Table 51. Jiangsu GDK Flu Vaccine Sales Quantity (M Doses), Average Price (USD/Doses), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 52. Jiangsu GDK Recent Developments/Updates
    Table 53. KM Biologics Basic Information, Manufacturing Base and Competitors
    Table 54. KM Biologics Major Business
    Table 55. KM Biologics Flu Vaccine Product and Services
    Table 56. KM Biologics Flu Vaccine Sales Quantity (M Doses), Average Price (USD/Doses), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 57. KM Biologics Recent Developments/Updates
    Table 58. Global Flu Vaccine Sales Quantity by Manufacturer (2018-2023) & (M Doses)
    Table 59. Global Flu Vaccine Revenue by Manufacturer (2018-2023) & (USD Million)
    Table 60. Global Flu Vaccine Average Price by Manufacturer (2018-2023) & (USD/Doses)
    Table 61. Market Position of Manufacturers in Flu Vaccine, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
    Table 62. Head Office and Flu Vaccine Production Site of Key Manufacturer
    Table 63. Flu Vaccine Market: Company Product Type Footprint
    Table 64. Flu Vaccine Market: Company Product Application Footprint
    Table 65. Flu Vaccine New Market Entrants and Barriers to Market Entry
    Table 66. Flu Vaccine Mergers, Acquisition, Agreements, and Collaborations
    Table 67. Global Flu Vaccine Sales Quantity by Region (2018-2023) & (M Doses)
    Table 68. Global Flu Vaccine Sales Quantity by Region (2024-2029) & (M Doses)
    Table 69. Global Flu Vaccine Consumption Value by Region (2018-2023) & (USD Million)
    Table 70. Global Flu Vaccine Consumption Value by Region (2024-2029) & (USD Million)
    Table 71. Global Flu Vaccine Average Price by Region (2018-2023) & (USD/Doses)
    Table 72. Global Flu Vaccine Average Price by Region (2024-2029) & (USD/Doses)
    Table 73. Global Flu Vaccine Sales Quantity by Type (2018-2023) & (M Doses)
    Table 74. Global Flu Vaccine Sales Quantity by Type (2024-2029) & (M Doses)
    Table 75. Global Flu Vaccine Consumption Value by Type (2018-2023) & (USD Million)
    Table 76. Global Flu Vaccine Consumption Value by Type (2024-2029) & (USD Million)
    Table 77. Global Flu Vaccine Average Price by Type (2018-2023) & (USD/Doses)
    Table 78. Global Flu Vaccine Average Price by Type (2024-2029) & (USD/Doses)
    Table 79. Global Flu Vaccine Sales Quantity by Application (2018-2023) & (M Doses)
    Table 80. Global Flu Vaccine Sales Quantity by Application (2024-2029) & (M Doses)
    Table 81. Global Flu Vaccine Consumption Value by Application (2018-2023) & (USD Million)
    Table 82. Global Flu Vaccine Consumption Value by Application (2024-2029) & (USD Million)
    Table 83. Global Flu Vaccine Average Price by Application (2018-2023) & (USD/Doses)
    Table 84. Global Flu Vaccine Average Price by Application (2024-2029) & (USD/Doses)
    Table 85. North America Flu Vaccine Sales Quantity by Type (2018-2023) & (M Doses)
    Table 86. North America Flu Vaccine Sales Quantity by Type (2024-2029) & (M Doses)
    Table 87. North America Flu Vaccine Sales Quantity by Application (2018-2023) & (M Doses)
    Table 88. North America Flu Vaccine Sales Quantity by Application (2024-2029) & (M Doses)
    Table 89. North America Flu Vaccine Sales Quantity by Country (2018-2023) & (M Doses)
    Table 90. North America Flu Vaccine Sales Quantity by Country (2024-2029) & (M Doses)
    Table 91. North America Flu Vaccine Consumption Value by Country (2018-2023) & (USD Million)
    Table 92. North America Flu Vaccine Consumption Value by Country (2024-2029) & (USD Million)
    Table 93. Europe Flu Vaccine Sales Quantity by Type (2018-2023) & (M Doses)
    Table 94. Europe Flu Vaccine Sales Quantity by Type (2024-2029) & (M Doses)
    Table 95. Europe Flu Vaccine Sales Quantity by Application (2018-2023) & (M Doses)
    Table 96. Europe Flu Vaccine Sales Quantity by Application (2024-2029) & (M Doses)
    Table 97. Europe Flu Vaccine Sales Quantity by Country (2018-2023) & (M Doses)
    Table 98. Europe Flu Vaccine Sales Quantity by Country (2024-2029) & (M Doses)
    Table 99. Europe Flu Vaccine Consumption Value by Country (2018-2023) & (USD Million)
    Table 100. Europe Flu Vaccine Consumption Value by Country (2024-2029) & (USD Million)
    Table 101. Asia-Pacific Flu Vaccine Sales Quantity by Type (2018-2023) & (M Doses)
    Table 102. Asia-Pacific Flu Vaccine Sales Quantity by Type (2024-2029) & (M Doses)
    Table 103. Asia-Pacific Flu Vaccine Sales Quantity by Application (2018-2023) & (M Doses)
    Table 104. Asia-Pacific Flu Vaccine Sales Quantity by Application (2024-2029) & (M Doses)
    Table 105. Asia-Pacific Flu Vaccine Sales Quantity by Region (2018-2023) & (M Doses)
    Table 106. Asia-Pacific Flu Vaccine Sales Quantity by Region (2024-2029) & (M Doses)
    Table 107. Asia-Pacific Flu Vaccine Consumption Value by Region (2018-2023) & (USD Million)
    Table 108. Asia-Pacific Flu Vaccine Consumption Value by Region (2024-2029) & (USD Million)
    Table 109. South America Flu Vaccine Sales Quantity by Type (2018-2023) & (M Doses)
    Table 110. South America Flu Vaccine Sales Quantity by Type (2024-2029) & (M Doses)
    Table 111. South America Flu Vaccine Sales Quantity by Application (2018-2023) & (M Doses)
    Table 112. South America Flu Vaccine Sales Quantity by Application (2024-2029) & (M Doses)
    Table 113. South America Flu Vaccine Sales Quantity by Country (2018-2023) & (M Doses)
    Table 114. South America Flu Vaccine Sales Quantity by Country (2024-2029) & (M Doses)
    Table 115. South America Flu Vaccine Consumption Value by Country (2018-2023) & (USD Million)
    Table 116. South America Flu Vaccine Consumption Value by Country (2024-2029) & (USD Million)
    Table 117. Middle East & Africa Flu Vaccine Sales Quantity by Type (2018-2023) & (M Doses)
    Table 118. Middle East & Africa Flu Vaccine Sales Quantity by Type (2024-2029) & (M Doses)
    Table 119. Middle East & Africa Flu Vaccine Sales Quantity by Application (2018-2023) & (M Doses)
    Table 120. Middle East & Africa Flu Vaccine Sales Quantity by Application (2024-2029) & (M Doses)
    Table 121. Middle East & Africa Flu Vaccine Sales Quantity by Region (2018-2023) & (M Doses)
    Table 122. Middle East & Africa Flu Vaccine Sales Quantity by Region (2024-2029) & (M Doses)
    Table 123. Middle East & Africa Flu Vaccine Consumption Value by Region (2018-2023) & (USD Million)
    Table 124. Middle East & Africa Flu Vaccine Consumption Value by Region (2024-2029) & (USD Million)
    Table 125. Flu Vaccine Raw Material
    Table 126. Key Manufacturers of Flu Vaccine Raw Materials
    Table 127. Flu Vaccine Typical Distributors
    Table 128. Flu Vaccine Typical Customers
List of Figures
    Figure 1. Flu Vaccine Picture
    Figure 2. Global Flu Vaccine Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
    Figure 3. Global Flu Vaccine Consumption Value Market Share by Type in 2022
    Figure 4. Trivalent Influenza Vaccine Examples
    Figure 5. Quadrivalent Influenza Vaccine Examples
    Figure 6. Global Flu Vaccine Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
    Figure 7. Global Flu Vaccine Consumption Value Market Share by Application in 2022
    Figure 8. 6 Months to 3 Years Examples
    Figure 9. > 3 Years Examples
    Figure 10. Global Flu Vaccine Consumption Value, (USD Million): 2018 & 2022 & 2029
    Figure 11. Global Flu Vaccine Consumption Value and Forecast (2018-2029) & (USD Million)
    Figure 12. Global Flu Vaccine Sales Quantity (2018-2029) & (M Doses)
    Figure 13. Global Flu Vaccine Average Price (2018-2029) & (USD/Doses)
    Figure 14. Global Flu Vaccine Sales Quantity Market Share by Manufacturer in 2022
    Figure 15. Global Flu Vaccine Consumption Value Market Share by Manufacturer in 2022
    Figure 16. Producer Shipments of Flu Vaccine by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
    Figure 17. Top 3 Flu Vaccine Manufacturer (Consumption Value) Market Share in 2022
    Figure 18. Top 6 Flu Vaccine Manufacturer (Consumption Value) Market Share in 2022
    Figure 19. Global Flu Vaccine Sales Quantity Market Share by Region (2018-2029)
    Figure 20. Global Flu Vaccine Consumption Value Market Share by Region (2018-2029)
    Figure 21. North America Flu Vaccine Consumption Value (2018-2029) & (USD Million)
    Figure 22. Europe Flu Vaccine Consumption Value (2018-2029) & (USD Million)
    Figure 23. Asia-Pacific Flu Vaccine Consumption Value (2018-2029) & (USD Million)
    Figure 24. South America Flu Vaccine Consumption Value (2018-2029) & (USD Million)
    Figure 25. Middle East & Africa Flu Vaccine Consumption Value (2018-2029) & (USD Million)
    Figure 26. Global Flu Vaccine Sales Quantity Market Share by Type (2018-2029)
    Figure 27. Global Flu Vaccine Consumption Value Market Share by Type (2018-2029)
    Figure 28. Global Flu Vaccine Average Price by Type (2018-2029) & (USD/Doses)
    Figure 29. Global Flu Vaccine Sales Quantity Market Share by Application (2018-2029)
    Figure 30. Global Flu Vaccine Consumption Value Market Share by Application (2018-2029)
    Figure 31. Global Flu Vaccine Average Price by Application (2018-2029) & (USD/Doses)
    Figure 32. North America Flu Vaccine Sales Quantity Market Share by Type (2018-2029)
    Figure 33. North America Flu Vaccine Sales Quantity Market Share by Application (2018-2029)
    Figure 34. North America Flu Vaccine Sales Quantity Market Share by Country (2018-2029)
    Figure 35. North America Flu Vaccine Consumption Value Market Share by Country (2018-2029)
    Figure 36. United States Flu Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 37. Canada Flu Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 38. Mexico Flu Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 39. Europe Flu Vaccine Sales Quantity Market Share by Type (2018-2029)
    Figure 40. Europe Flu Vaccine Sales Quantity Market Share by Application (2018-2029)
    Figure 41. Europe Flu Vaccine Sales Quantity Market Share by Country (2018-2029)
    Figure 42. Europe Flu Vaccine Consumption Value Market Share by Country (2018-2029)
    Figure 43. Germany Flu Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 44. France Flu Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 45. United Kingdom Flu Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 46. Russia Flu Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 47. Italy Flu Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 48. Asia-Pacific Flu Vaccine Sales Quantity Market Share by Type (2018-2029)
    Figure 49. Asia-Pacific Flu Vaccine Sales Quantity Market Share by Application (2018-2029)
    Figure 50. Asia-Pacific Flu Vaccine Sales Quantity Market Share by Region (2018-2029)
    Figure 51. Asia-Pacific Flu Vaccine Consumption Value Market Share by Region (2018-2029)
    Figure 52. China Flu Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 53. Japan Flu Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 54. Korea Flu Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 55. India Flu Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 56. Southeast Asia Flu Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 57. Australia Flu Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 58. South America Flu Vaccine Sales Quantity Market Share by Type (2018-2029)
    Figure 59. South America Flu Vaccine Sales Quantity Market Share by Application (2018-2029)
    Figure 60. South America Flu Vaccine Sales Quantity Market Share by Country (2018-2029)
    Figure 61. South America Flu Vaccine Consumption Value Market Share by Country (2018-2029)
    Figure 62. Brazil Flu Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 63. Argentina Flu Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 64. Middle East & Africa Flu Vaccine Sales Quantity Market Share by Type (2018-2029)
    Figure 65. Middle East & Africa Flu Vaccine Sales Quantity Market Share by Application (2018-2029)
    Figure 66. Middle East & Africa Flu Vaccine Sales Quantity Market Share by Region (2018-2029)
    Figure 67. Middle East & Africa Flu Vaccine Consumption Value Market Share by Region (2018-2029)
    Figure 68. Turkey Flu Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 69. Egypt Flu Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 70. Saudi Arabia Flu Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 71. South Africa Flu Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 72. Flu Vaccine Market Drivers
    Figure 73. Flu Vaccine Market Restraints
    Figure 74. Flu Vaccine Market Trends
    Figure 75. Porters Five Forces Analysis
    Figure 76. Manufacturing Cost Structure Analysis of Flu Vaccine in 2022
    Figure 77. Manufacturing Process Analysis of Flu Vaccine
    Figure 78. Flu Vaccine Industrial Chain
    Figure 79. Sales Quantity Channel: Direct to End-User vs Distributors
    Figure 80. Direct Channel Pros & Cons
    Figure 81. Indirect Channel Pros & Cons
    Figure 82. Methodology
    Figure 83. Research Process and Data Source

Companies Mentioned

Sanofi
CSL
GSK
Viatris
AstraZeneca
Hualan Bio
Changchun Institute of Biological
Sinovac
BCHT
Jiangsu GDK
KM Biologics